Karolinska Institutet, Department of Clinical Neuroscience, Section of psychiatry, Karolinska Hospital Solna R5
Stockholm, 171 76, Sweden
NCT Number: NCT00845260
Panic Disorder with or without agoraphobia (PD/A) is a common, and unless it is treated, often chronic psychiatric disorder. The are effective pharmacological as well as psychological treatments for PD/A. Because of the lack of availability of the most effective psychological treatment, cognitive behavior therapy (CBT), self-help based CBT treatments have been developed. One of those are Internet-based CBT. The aim of this study is to compare the effectiveness of Internet and group CBT for PD/A in a regular psychiatric setting. 113 patients are consecutively and randomly assigned to either treatment (both lasting 10 weeks). The main outcome measure is the Panic Disorder Severity Scale(PDSS). The study hypothesis is that treatments will show equal effectiveness.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Stockholm, 171 76, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Self-help program and guidance by psychologist via e-mail during 10 weeks.
Group cognitive behavior therapy (CBT) during 10 weeks.
Time frame: Pre, post at 6-month follow-up
Time frame: Pre, post and 6-month follow-up
Karolinska Institutet
Other
Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial
Acronym: IP2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00705380
Anxiety Disorders, Mental Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT00576719
Agoraphobia, Anxiety Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT07424911
Anxiety Disorders, Mental Disorders
Elâzığ, Turkey (Türkiye)
View Trial DetailsNCT07268729
Anxiety, Anxiety Disorders
Mississauga, Ontario, Canada
View Trial Details